Problems of drug supply for patients with diabetes mellitus in the military health care and civilian health care

Abstract

Features of pharmacotherapy diabetes compose a significant financial burden on the budgets of civilian and military health care, which requires the rational and optimal allocation of resources. To date, the legislation is not regulated by the fact that the refusal to produce drugs under the program of the federal or regional drug supply does not prevent certain categories of benefit recipients to receive drugs from the budget of the Russian Defense Ministry, which is detrimental to the public system preferential drug coverage.